Welcome to Walk-Off Walk's first guest column. My friend Bryce has offered his thoughts on a certain pitcher and if you don't know who, please kindly read the title. Anyway, please read and I have some comments below. Maybe if you're nice to Bryce, he will continue to add to the blog.
------------------------------
The Atlanta Braves have what can only
be conceived as an enviable situation on their hands as the July 31st
non-waiver trade deadline approaches. Their rotation has remained
remarkably healthy through the All-Star break and no starter has
posted an ERA above 4 aside from rotation’s elder statesman, Tim Hudson (4.02). With the continuing rehab of Brandon Beachy and Alex Wood lurking nearby in the minor leagues, the Braves find themselves
with an excellent conundrum on their hands—an excess of starting
pitchers.
Obviously, this brings up a very real
question that must be answered. Who gets the boot, if anyone, when
Brandon Beachy completes his rehab assignment?
I’ve heard suggestions from many
different sources over the last month ranging from sending Kris Medlen or Julio Teheran to the bullpen to cap their innings loads, to
sending Maholm to the bullpen for his ability to handcuff lefties, to
simply sending Beachy to the bullpen for the remainder of the season.
Assuming Beachy does not suffer any
setbacks in his second set of rehab starts, none of the proposed
moves are incorrect. However, I’d like to shine the spotlight on a
possibility that I feel should be talked about, which isn’t
currently being discussed at all: Trading Paul Maholm.
I can hear the rebuttals coming, so I
will address a couple of the popular retorts that will arise from
this suggestion.
Are you nuts? Trade a healthy
workhorse and rely on a guy coming off surgery?
While it is unorthodox (and potentially
ill-advised) to do such a thing, Maholm has been the team’s
least productive starting pitcher according to WAR (0.7 in 19 starts)
and the least entrenched in the rotation and the hearts of Braves
fans.
Beyond that, the “guy coming off
surgery” is Beachy. The same guy who posted 1.3 WAR in 13
starts in 2012 before succumbing to Tommy John surgery. While it is
silly to expect that kind of output, the potential is something the
Braves need to get back into their rotation down the stretch.
If the Braves were to need a 6th
starting pitcher between August 1st and the end of the
season, there’s also the presence of Wood. If the Braves were
to need more than that, you could probably argue that they are in
bigger trouble than Maholm’s presence could have solved in the
first place.
Paul Maholm is average and a
rental. What do you really expect to get?
The first two statements are true.
Maholm is, in fact, average and a free agent-to-be. To the average
observer, those two things should limit his overall value in a trade.
However, those are not the only factors in play here.
The biggest factor, as always, is the
supply and demand of the trade market and as always the market is hot
for starting pitching.
Obviously, in a vacuum no contending
team is going to opt for Maholm over Matt Garza, but luckily for
the Braves that is not how things work. Only one team will be able to
satisfy the Cubs in a trade for the market’s top pitching prize and
once the Matt Garza domino falls, things will begin to fall into
place for the Atlanta Braves.
After Garza, the market drops off
steeply into an abyss of bad contracts and/or questionable
health/performance issues. Could I interest any contenders in Phil Hughes? No? How about Tim Lincecum at $8M for the remainder of the
season at the cost of a top prospect or two? How about Yovani Gallardo and his declining velocity/strikeout rate and contractual
obligation through 2015?
While I’m not here to run down every
option teams can look into, you can see why Maholm could quickly
float to upper echelon of the pile of available starting pitchers
when factoring in effectiveness, salary and future obligation. Maholm, if made available, would surely draw enough interest to get
the Braves something useful.
So what should the Braves look for?
Luckily, we have somewhat of a
precedent to look at: Scott Feldman.
Through 15 starts, Feldman posted
a 7-6 record with a 3.86 ERA and 1.15 WHIP for the Chicago Cubs
before being sent to Baltimore along with backup catcher Steve Clevenger in exchange for Jake Arrieta and Pedro Strop. Not bad for a
rental, I must say.
While I caution not to expect that much
(as Maholm’s peripherals don’t match up well to Feldman’s this
season) the Braves could reasonably expect to get someone useful out
of a trade involving Maholm. If not a major league bench piece, the
Braves could definitely get a useful young arm that could be
worthwhile in the future. Maybe a prospect like Eury De La Rosa out
of the Diamondbacks system; or a Brock Holt of the Boston Red Sox to
come off our bench.
----------------------
I agree with Bryce on trading Maholm if the package is there and it really should be, right? A few days ago, as part of the Stock Report series, I wrote, "Depending on how Beachy looks, Maholm seems like a possible trade possibility." That's AWFUL English and I should be smacked for writing a line like that, but the point remains and Bryce further investigates the point that depending on the health of Beachy, there is no better time than now to consider dealing Maholm. The package needed is up for debate. An exchange of rentals from one contender to another seems far-fetched, but possibly acquiring prospects, as Bryce points to, would allow the Braves to include a third team in a deal.
For instance, a contender needs to fortify their rotation. Consider the case of Cleveland, a team whose starting rotation allows 4.52 R/G. They could use Maholm and might surrender a package similar to the ones the Orioles gave up for Feldman. The Braves could use those prospects in a trade to acquire Jesse Crain from the Chicago White Sox.
That's just rosterbating, but potentially, Maholm's greatest value to the Braves could come in a trade rather than with him on the mound. Thank you Bryce for your post and comment with your thoughts.
No comments:
Post a Comment